ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.
about
Antidepressants for agitation and psychosis in dementiaAntidepressants for agitation and psychosis in dementiaUse of atypical antipsychotics in the elderly: a clinical reviewChallenge of changing nursing home prescribing cultureCaregiver and care recipient characteristics as predictors of psychotropic medication use in community-dwelling dementia patients.Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards.Can agitated behavior of nursing home residents with dementia be prevented with the use of standardized stimuli?Clinical Characteristics of Patients with Late Life Bipolar Disorder in the Community: Data from the NNDC Registry.Clinical practice with antidementia and antipsychotic drugs: Audit from a geriatric clinic in India.Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia.Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis.Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole.Delirium in advanced age and dementia: A prolonged refractory course of delirium and lower functional status.Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges.Profile and variables related to antipsychotic consumption according to dementia subtypes.Drug utilization pattern in patients with different types of dementia in Western India.When help becomes a hindrance: mental health referral systems as barriers to care for primary care physicians treating patients with Alzheimer's diseaseComparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.New wine in old bottle: late-life psychosisDelusional infestation.Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategiesAtypical antipsychotics for older adults: are they safe and effective as we once thought?Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia.Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients.Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort studyA retrospective, longitudinal study of factors associated with new antipsychotic medication use among recently admitted long-term care residents.Comparative safety of antipsychotic medications in nursing home residentsAlzheimer's disease: diagnosis and treatment across the spectrum of disease severityAssociation of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons.Antipsychotic Use in a Diverse Population With Dementia: A Retrospective Review of the National Alzheimer's Coordinating Center DatabasePersistent use of psychotropic drugs in nursing home residents in Norway.Atypical antipsychotic use in patients with dementia: managing safety concerns.Vasculopathy related to manic/hypomanic symptom burden and first-generation antipsychotics in a sub-sample from the collaborative depression studyCuring and caring: the work of primary care physicians with dementia patients.Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practiceManagement of insomnia: update and new approaches.Association of posttraumatic stress disorder with increased prevalence of metabolic syndrome.Establishing test-retest reliability of an adapted [(18)F]fallypride imaging protocol in older people.
P2860
Q24236550-7D210485-CF19-43A5-AE2F-375D05A5462DQ24241426-E8150376-02F1-4041-ABB4-ED27339FED00Q26827756-186B5682-6054-484B-ACC4-88A0F011EB38Q26865397-2CFBD432-55E6-40B1-AED3-6916C6520111Q30275696-2F6780BA-3B6E-42B3-A65E-8E159D53D5C7Q30374315-D8556D67-89F2-4A91-9A34-3278A2F5ECFEQ30390736-E8742187-1D97-4F82-ABDD-9FDB49364303Q30891260-41AB90BF-4D9A-4F7E-B78D-1AA98011D503Q33574426-72FAE6A5-465C-42C5-82ED-962E9A8EF519Q33591977-8C4738F5-5802-44A2-A7A2-113A454531BFQ33605869-5BFAEB86-E064-4316-86EC-DAFDDF64FDA8Q33650097-E7F8345D-03FA-474F-AECD-D2F731FC09F4Q33755676-029ED4CD-0A0A-4B88-9388-BB2A9A164D4CQ33925658-AD7D8458-3164-4D1D-89F9-9DC50C653E25Q33960193-B7EFA846-8B16-43EB-BDEC-8865971E71ADQ34158495-4AECA091-81A2-4009-BE44-C5524DDF7A0CQ34176659-33796EE2-B82B-47A5-9C6D-D33B403A2D7FQ34200568-2C7003E9-39A6-4508-A15A-CCAFA2877523Q34646095-FB808351-7785-4A63-975A-089F0B3F1ACFQ34828788-C48A307B-8E69-4746-A268-3E3DA0835E8EQ34976609-0D5D20B7-5B4B-43D5-B51B-467B3ED3147DQ35007629-EE75501B-8CB3-44ED-B5AA-8303CC8D9EF2Q35523924-F8AAE540-A537-4D97-879E-86D9ADB701A1Q35565618-EE49F4B4-F3F0-4B3C-9EF5-53FAF9FE109AQ35593200-3602195A-FF2F-4743-9BB5-A1D7B0487970Q35627432-0DA2B355-B8E2-415E-933D-08093230CB4EQ35775454-9C569A14-F114-4A3D-B554-2ECB57CA946AQ35813455-77EB2465-B846-4CEC-AC1B-383CF0EE53DFQ35828059-311A44EE-10E4-4005-8AF2-1513BF774EEFQ35860723-26D8106C-3D41-4C97-8379-0B0A57225F74Q36141743-BAFDB128-9628-43E4-8B37-9FDDF548214CQ36198582-E82194D4-C3E1-4FF4-B601-CD542592DF87Q36279048-C9826C64-2F2B-461D-849D-A5D5B73ECA32Q36450333-5F9D594D-BF2F-46E5-A874-CA07FA92BA3CQ36597036-B90AA1F4-21B2-498F-9834-C354D90D1846Q36636371-8CEE5497-ED70-490C-9888-F8FF1F15DFEAQ36728558-BE101589-91BC-45B5-8F83-9D7B24CC3342Q36779811-A37C7B41-AF54-47A5-A4E3-43B1663A1A1FQ36807102-A16A8DE5-C016-4C7E-A701-73461BB3A433Q36994341-82A6FF1E-2024-4CFC-B293-D4E7433AD4A5
P2860
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.
@en
type
label
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.
@en
prefLabel
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.
@en
P2093
P2860
P356
P1476
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.
@en
P2093
Carl Salzman
Dan Blazer
Daniel Casey
Lon Schneider
Pierre Tariot
Thomas Meeks
P2860
P2888
P304
P356
10.1038/SJ.NPP.1301492
P407
P577
2007-07-18T00:00:00Z
P5875
P6179
1021191280